Work

[Comparison of the efficacy of continuous VA chemotherapy and I/HDAC consolidation in postremission therapy for acute myeloid leukemia fit for standard chemotherapy].

Year: 2025

Type: article

Abstract: I/HDAC consolidation was more likely to help get survival benefits for patients with ELN favorable-risk, positive MRD, wild type FLT3, or IDH1/2 mutation. Continuous VA chemotherapy exhibited superior safety than I/HDAC consolidation.

Source: PubMed

DOI: 10.3760/cma.j.cn121090-20240529-00198

Authors: L Sun, P P Zhang, S M Ren, N Zhou, L Y Li, Z Z Wang, W G Cui, F Yang, J M Luo, L Yang

Institutions: Hebei Medical University, Second Hospital of Hebei Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Hospital, National Center for Clinical Laboratories

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4410840944

FWCI:

Cites:

Cited by:

Related to: 10